Alteration in endogenous opioid systems due to chronic inflammatory pain conditions

By Spetea M.   Rydelius G.   Nylander I.   Ahmed M.   Bileviciute-Ljungar I.   Lundeberg T.   Svensson S.   Kreicbergs A.  

European Journal of Pharmacology, Vol. 435, Iss. 2, 2002-01 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

SNew Trends in the Development of Opioid Peptide Analogues as Advanced Remedies for Pain Relief

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 1, 2004-01 ,pp. : 19-38

Bentham Science Publishers

Access to resources Recommend Favorite

The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients

By Reddy Akhila   Tayjasanant Supakarn   Haider Ali   Heung Yvonne   Wu Jimin   Liu Diane   Yennurajalingam Sriram   Reddy Suresh   de la Cruz Maxine   Rodriguez Eden Mae   Waletich Jessica   Vidal Marieberta   Arthur Joseph   Holmes Carolyn   Tallie Kimmie   Wong Angelique   Dev Rony   Williams Janet   Bruera Eduardo  

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 149-156

Blackwell Publishing

Access to resources Recommend Favorite

Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study

By Karasek Petr   Skacel Tomas   Kocakova Ilona   Bednarik Otakar   Petruzelka Lubos   Melichar Bohuslav   Bustova Ivana   Spurny Vladimir   Trason Tomas  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 581-586

Informa Healthcare

Access to resources Recommend Favorite

Bedside clinical signs associated with impending death in patients with advanced cancer: Preliminary findings of a prospective, longitudinal cohort study

By Hui David   dos Santos Renata   Chisholm Gary   Bansal Swati   Souza Crovador Camila   Bruera Eduardo  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 960-967

Blackwell Publishing

Access to resources Recommend Favorite